A versatile microfluidic platform for malaria infection screening and Plasmodium species genotyping.

Authors:
Xiu L; Li H; Hu Q; Zhang Y; Chen SB and 4 more

Journal:
EBioMedicine

Publication Year: 2023

DOI:
10.1016/j.ebiom.2023.104898

PMCID:
PMC10697993

PMID:
38029461

View on PubMed View on PMC View Publisher
Journal Information

Full Title: EBioMedicine

Abbreviation: EBioMedicine

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Genetics, Medical

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
A 14-gene B-cell immune signature in early-stage triple-negative breast cancer (TNBC): a pooled ana…
Conte B; Brasó-Maristany F; Hernández AR and 23 more (2024) - Transparency Score: 4/6
Accelerometer-based physical activity is associated with the gut microbiota in 8416 individuals in …
Baldanzi G; Sayols-Baixeras S; Ekblom-Bak E and 17 more (2024) - Transparency Score: 3/6
Adults with metabolically healthy overweight or obesity present more brown adipose tissue and highe…
Jurado-Fasoli L; Sanchez-Delgado G; Alcantara JMA and 6 more (2024) - Transparency Score: 3/6
Advancing dengue vaccination using a T-cell priming peptide approach.
Farias JP; Birbrair A; Amorim JH. (2024) - Transparency Score: 2/6
Characterization of a human H3N8 influenza virus.
Gu C; Fan S; Dahn R and 7 more (2024) - Transparency Score: 4/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declaration of interests Leshan Xiu, Kun Yin and Huimin Li have a patent (People's Republic of China) related to this article. All other authors declare no competing interests."

Evidence found in paper:

"This work was financially supported by the International Joint Laboratory on Tropical Diseases Control in Greater Mekong Subregion (21410750200), 10.13039/501100001809National Natural Science Foundation of China (22104090), the Natural Science Foundation of Shanghai (22ZR1436200), National Research and Development Plan of China (2020YFE0205700 and 2018YFE0121600), the Health Research in the Public Interest (201202019) and the project from Bill & Melinda Gates foundation (INV-003421)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025